24 Sep 2024

ADIoS

Rx-info Ltd Stand: G50

Diversion of controlled drugs is a continuing source of concern to the Care Quality Commission and despite strengthened controls it has underlined that there is no room for complacency.
Rx-info devised ADIoS almost 20 years ago to provide NHS Trust Accountable Officers with a robust system for monitoring and reporting on controlled and abusable drugs including schedules 4 + 5.
The latest version is compliant with CQC recommendations and NICE guidance.

ADIoS has a proven track record of enhancing security and accountability of drug usage in trusts across the country. It runs on the trusted Define platform.
The software monitors around 1,200 drug formulations for a hospital, with a simplified visual display that tracks back to ward-level. Viewing the data over a period of time enables the hospital to ensure the safety and accountability of abusable drugs.

ADIoS:
● Allows Controlled Drug audits to be completed
● Identifies likely areas where diversion may be taking place
● Supports the management of incidents following diversion
● Shows patterns of diversion across an organisation
● Supports Local Intelligence Network meetings
● Tracks more than 1,600 abusable drugs (including schedules 4 & 5 Controlled Drugs).

View all CPC North Exhibitor Products
Loading